Vplyv ultraspracovaných potravín na dyslipidémiu
The impact of ultra-processed foods on dyslipidemia
Ultra-processed foods (UPF) are characterized as food products mainly composed of cheap industrial ingredients, additives, and newly created products, often with little or no nutritional value. The poor nutrient composition of UPF is one of the proposed mechanisms linking them to adverse health outcomes. UPF generally have higher energy, saturated or trans fats, sugar, cholesterol, and salt content, while lacking essential nutrients. The relationship between UPF and dyslipidemia has been examined in several observational studies. The results of these studies support a possible association between UPF intake and dyslipidemia, mainly showing a link with the risk of elevated triglyceride levels and low HDL, but the evidence is limited by the size and methodological quality of the studies published so far.
Keywords:
triglycerides – dyslipidemia – HDL-cholesterol (HDL-C) – ultra-processed foods (UPF)
Authors:
Jana Lisičanová 1; Branislav Vohnout 1,2
Authors‘ workplace:
Diabetologická ambulancia, Diabeda s. r. o., Bratislava
1; Ústav výživy, Fakulta ošetrovateľstva a zdravotníckych odborných štúdií a Koordinačné centrum pre familiárne hyperlipoproteinémie, SZU, Bratislava
2
Published in:
AtheroRev 2026; 11(1): 64-66
Category:
Reviews
Overview
Ultraspracované potraviny (UPF) sú charakterizované ako potravinárske výrobky zložené predovšetkým z lacných priemyselných zložiek, prísad a novovytvorených produktov, často s malou alebo žiadnou nutričnou hodnotou. Zlé zloženie živín v UPF je jedným z predpokladaných mechanizmov, ktoré ich spájajú s nepriaznivými zdravotnými následkami. UPF majú v priemere vyšší obsah energie, nasýtených alebo transtukov, cukru, cholesterolu a soli, pričom im chýbajú esenciálne živiny. Vzťah medzi UPF a dyslipidémiami bol sledovaný vo viacerých observačných štúdiách. Výsledky týchto štúdií podporujú možnú súvislosť medzi príjmom UPF a dyslipidémiou, ukazuje sa hlavne súvislosť s rizikom zvýšených hladín triglyceridov a nízkej hladiny HDL-cholesterolu, dôkazy sú však limitované veľkosťou a metodologickou kvalitou doteraz publikovaných štúdií.
Klíčová slova:
triglyceridy – dyslipidémia – HDL-cholesterol (HDL-C) – ultraspracované potraviny (UPF)
Sources
1. Willett WC, Sacks F, Trichopoulou A et al. Mediterranean diet pyramid: a cultural model for healthy eating. Am J Clin Nutr 1995; 61(6 Suppl): 1402S1406S. Dostupné z DOI: <https://doi 10.1093/ajcn/61.6.1402S>.
2. Fernandez ML, Raheem D, Ramos F et al. Highlights of Current Dietary Guidelines in Five Continents. Int J Environ Res Public Health 2021; 18(6): 2814. Dostupné z DOI: <https://doi 10.3390/ijerph18062814>.
3. Vlassopoulos A, Katidi A, Savvidou T et al. Alignment of NutriScore with Mediterranean Diet Pyramid: A Food Level Analysis. Nutrients 2022; 14(23): 5097. Dostupné z DOI: <https://doi.org/10.3390/nu14235097>.
4. Mach F, Baigent C, Catapano AL et al. [ESC Scientific Document Group]. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 2020; 41(1): 111–188. Dostupné z DOI: <https://doi 10.1093/eurheartj/ehz455>.
5. Popkin BM, Miles DR, Taillie LS et al. A policy approach to identifying food and beverage products that are ultraprocessed and high in added salt, sugar and saturated fat in the United States: a crosssectional analysis of packaged foods. Lancet Reg Health Am 2024; 32 : 100713. Dostupné z DOI: <https://doi 10.1016/j.lana.2024.100713>.
6. Monteiro CA, Astrup A. Does the concept of “ultraprocessed foods” help inform dietary guidelines, beyond conventional classification systems? YES. Am J Clin Nutr 2022; 116(6): 1476–1481. Dostupné z DOI: <https://doi 10.1093/ajcn/nqac122>.
7. Astrup A, Monteiro CA. Does the concept of “ultraprocessed foods” help inform dietary guidelines, beyond conventional classification systems? Debate consensus. Am J Clin Nutr 2022; 116(6): 1489–1491. Dostupné z DOI: <https://doi 10.1093/ajcn/nqac230>.
8. Monteiro CA, Cannon G, Levy RB et al. Ultraprocessed foods: what they are and how to identify them. Public Health Nutr 2019; 22(5): 936–941. Dostupné z DOI: <https://doi 10.1017/S1368980018003762>.
9. Monteiro CA, Cannon G, Lawrence M et al. Ultraprocessed foods, diet quality, and health using the NOVA classification system. FAO: Rome 2019. ISBN 978–92–5131701–3. Dostupné z WWW: <https://openknowledge.fao.org/server/api/core/bitstreams/5277b379–0acb4d97a6a3–602774104629/content>.
10. Monteiro CA. Nutrition and health. The issue is not food, nor nutrients, so much as processing. Public Health Nutr 2009; 12(5): 729–731. Dostupné z DOI: <https://doi 10.1017/S1368980009005291>.
11. Touvier M, da Costa Louzada ML, Mozaffarian D et al. Ultraprocessed foods and cardiometabolic health: public health policies to reduce consumption cannot wait. BMJ 2023; 383: e075294. Dostupné z DOI: <https:// doi 10.1136/bmj2023–075294>.
12. Mertens E, Colizzi C, Penalvo JL. Ultraprocessed food consumption in adults across Europe. Eur J Nutr 2022; 61(3): 1521–1539. Dostupné z DOI: <https://doi 10.1007/s00394–021–02733–7>.
13. MartinezSteele E, Khandpur N, Batis C et al. Best practices for applying the NOVA food classification system. Nat Food 2023; 4(6): 445–448. Dostupné z DOI: <https://doi 10.1038/s43016–023–00779w>.
14. Bestari FF, Andarwulan N, Palupi E. Synthesis of Effect Sizes on Dose Response from UltraProcessed Food Consumption against Various Noncommunicable Diseases. Foods 2023; 12(24): 4457. Dostupné z DOI: <https://doi 10.3390/foods12244457>.
15. Mambrini SP, Menichetti F, Ravella S et al. UltraProcessed Food Consumption and Incidence of Obesity and Cardiometabolic Risk Factors in Adults: A Systematic Review of Prospective Studies. Nutrients 2023; 15(11): 2583. Dostupné z DOI: <https://doi 10.3390/nu15112583>.
16. Pagliai G, Dinu M, Madarena MP et al. Consumption of ultraprocessed foods and health status: a systematic review and metaanalysis. Br J Nutr 2021; 125(3): 308–318. Dostupné z DOI: <https://doi 10.1017/ S0007114520002688>.
17. Millar SR, Harrington JM, Perry IJ et al. Ultraprocessed food and drink consumption and lipoprotein subclass profiles: A crosssectional study of a middleto olderaged population. Clin Nutr 2024; 43(9): 1972–1980. Dostupné z DOI: <https://doi 10.1016/j.clnu.2024.07.007>.
18. Nouri M, Davies IG, Webb RJ et al. The association between ultraprocessed foods and conventional markers of cardiovascular risk in an adult Iranian population. Nutr Metab Cardiovasc Dis 2023; 33(10): 1951–1959. Dostupné z DOI: <https://doi 10.1016/j.numecd.2023.06.009>.
19. Nouri M, Eskandarzadeh S, Makhtoomi M et al. Association between ultraprocessed foods intake with lipid profile: a crosssectional study. Sci Rep 2023; 13(1): 7258. Dostupné z DOI: <https://doi 10.1038/ s41598–023–34451x>.
20. Vitale M, Costabile G, Testa R et al. UltraProcessed Foods and Human Health: A Systematic Review and MetaAnalysis of Prospective Cohort Studies. Adv Nutr 2024; 15(1): 100121. Dostupné z DOI: <https://doi 10.1016/j.advnut.2023.09.009>.
21. Dai S, Wellens J, Yang N et al. Ultraprocessed foods and human health: An umbrella review and updated metaanalyses of observational evidence. Clin Nutr 2024; 43(6): 1386–1394. Dostupné z DOI: <https://doi 10.1016/j. clnu.2024.04.016>.
22. Lane MM, Gamage E, Du S et al. Ultraprocessed food exposure and adverse health outcomes: umbrella review of epidemiological metaanalyses. BMJ 2024; 384: e077310. Dostupné z DOI: <https://doi 10.1136/ bmj2023–077310>.
23. Rauber F, Campagnolo PD, Hoffman DJ et al. Consumption of ultraprocessed food products and its effects on children’s lipid profiles: a longitudinal study. Nutr Metab Cardiovasc Dis 2015; 25(1): 116–122. Dostupné z DOI: <https://doi 10.1016/j.numecd.2014.08.001>.
24. Leffa PS, Hoffman DJ, Rauber F et al. Longitudinal associations between ultraprocessed foods and blood lipids in childhood. Br J Nutr 2020; 124(3): 341–348. Dostupné z DOI: <https://doi 10.1017/S0007114520001233>.
Labels
Angiology Diabetology Internal medicine Cardiology General practitioner for adultsArticle was published in
Athero Review
2026 Issue 1
- Hope Awakens with Early Diagnosis of Parkinson's Disease Based on Skin Odor
- The Importance of Hydration in Wound Healing
- Deep stimulation of the globus pallidus improved clinical symptoms in a patient with refractory parkinsonism and genetic mutation
- Safety and Tolerance of Metamizole in Postoperative Analgesia in Children
-
All articles in this issue
- Aktualizované odporúčania ESC/EAS 2025: dyslipidémia v centre modernej kardiovaskulárnej prevencie
- Postavenie kombinovanej liečby v kontexte aktualizácie odporúčaní ESC/EAS pre manažment dyslipidémií
- Kyselina bempedoová v aktualizovaných odporúčaniach pre manažment dyslipidémií ESC/EAS 2025
- Cieľové hladiny LDL-cholesterolu vo vysokorizikovej populácii na Slovensku: retrospektívna štúdia
- Steatotická choroba pečene asociovaná s metabolickou dysfunkciou: od patogenézy ku klinickým kardio-metabolickým implikáciám
- Aktuálny pohľad na lipoproteín(a): diagnostika a liečba
- Redukcia rizika aterosklerózy a kardiovaskulárneho rizika u pacientov liečených GLP1-RA
- Pacienti s HIV – manažment dyslipidémie, artériovej hypertenzie a kariovaskulárneho rizika: nové výzvy v ére efektívnej antiretrovírusovej liečby
- Prevencia kardiotoxicity antracyklínovej liečby ako nová potenciálna indikácia pre statíny?
- Umelá inteligencia v manažmente kardiovaskulárneho rizika: od digitálnej anamnézy k personalizovanej terapii
- Vplyv ultraspracovaných potravín na dyslipidémiu
- Rešerše zajímavých článků ze zahraniční literatury
- Rok 2025 – rok významných kardiologických studií
- Athero Review
- Journal archive
- Current issue
- About the journal
Most read in this issue
- Aktuálny pohľad na lipoproteín(a): diagnostika a liečba
- Aktualizované odporúčania ESC/EAS 2025: dyslipidémia v centre modernej kardiovaskulárnej prevencie
- Cieľové hladiny LDL-cholesterolu vo vysokorizikovej populácii na Slovensku: retrospektívna štúdia
- Postavenie kombinovanej liečby v kontexte aktualizácie odporúčaní ESC/EAS pre manažment dyslipidémií